S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSE:NSPR

InspireMD (NSPR) Stock Price, News & Analysis

$2.37
+0.09 (+3.95%)
(As of 03/28/2024 ET)
Today's Range
$2.22
$2.45
50-Day Range
$2.26
$3.15
52-Week Range
$0.96
$3.85
Volume
58,882 shs
Average Volume
23,893 shs
Market Capitalization
$55.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.85

InspireMD MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
104.6% Upside
$4.85 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of InspireMD in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.61) to ($0.50) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.70 out of 5 stars

Medical Sector

712th out of 938 stocks

Surgical & Medical Instruments Industry

73rd out of 94 stocks

NSPR stock logo

About InspireMD Stock (NYSE:NSPR)

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

NSPR Stock Price History

NSPR Stock News Headlines

[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
Preview: InspireMD's Earnings
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
NSPR Mar 2024 7.500 call
InspireMD earnings: here's what Wall Street expects
InspireMD Q3 2023 Earnings Preview
Piper Sandler Remains a Buy on InspireMD (NSPR)
See More Headlines
Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
3/29/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
65
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.85
High Stock Price Target
$5.20
Low Stock Price Target
$4.50
Potential Upside/Downside
+104.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-19,920,000.00
Net Margins
-320.97%
Pretax Margin
-319.92%

Debt

Sales & Book Value

Annual Sales
$6.20 million
Book Value
$1.83 per share

Miscellaneous

Free Float
18,386,000
Market Cap
$55.60 million
Optionable
Optionable
Beta
0.84
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Marvin L. Slosman (Age 60)
    President, CEO & Director
    Comp: $696.81k
  • Mr. Craig Shore (Age 63)
    CFO, Chief Administrative Officer, Secretary & Treasurer
    Comp: $625.24k
  • Mr. Andrea Tommasoli (Age 52)
    Chief Operating Officer
    Comp: $359.27k
  • Mr. Amir Kohen
    Vice President of Finance & Human Resources
  • Mr. Shane Thomas Gleason (Age 49)
    Chief Commercial Officer
  • Dr. Patrick A. Verta DVM (Age 66)
    M.D., MS Stat, Executive Vice President of Clinical & Medical Affairs
  • Mr. Pete Ligotti
    Executive VP & GM of North America
  • Dr. Sol J. Barer Ph.D. (Age 77)
    Special Advisor to the Board
    Comp: $13.92k

NSPR Stock Analysis - Frequently Asked Questions

Should I buy or sell InspireMD stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NSPR shares.
View NSPR analyst ratings
or view top-rated stocks.

What is InspireMD's stock price target for 2024?

1 brokers have issued 12-month price targets for InspireMD's shares. Their NSPR share price targets range from $4.50 to $5.20. On average, they expect the company's share price to reach $4.85 in the next twelve months. This suggests a possible upside of 104.6% from the stock's current price.
View analysts price targets for NSPR
or view top-rated stocks among Wall Street analysts.

How have NSPR shares performed in 2024?

InspireMD's stock was trading at $2.81 at the beginning of 2024. Since then, NSPR shares have decreased by 15.7% and is now trading at $2.3701.
View the best growth stocks for 2024 here
.

When is InspireMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NSPR earnings forecast
.

How were InspireMD's earnings last quarter?

InspireMD, Inc. (NYSE:NSPR) announced its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.04. The business had revenue of $1.76 million for the quarter, compared to analysts' expectations of $1.65 million. InspireMD had a negative net margin of 320.97% and a negative trailing twelve-month return on equity of 55.71%. During the same period in the prior year, the business posted ($0.60) earnings per share.

What other stocks do shareholders of InspireMD own?
Who are InspireMD's major shareholders?

InspireMD's stock is owned by many different retail and institutional investors. Top institutional investors include Nantahala Capital Management LLC (9.59%), Northern Trust Corp (0.13%), McKinley Carter Wealth Services Inc. (0.05%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gary S Roubin and Paul Stuka.
View institutional ownership trends
.

How do I buy shares of InspireMD?

Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NSPR) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners